StonvexLoading…
StonvexStonvexStonvexCore line items from CRBG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $18.48B | $18.71B | $18.80B | $24.70B |
Operating Income | $-541.00M | $2.80B | $940.00M | $10.49B |
Net Income | $-366.00M | $2.23B | $1.10B | $8.16B |
EPS (Diluted) | $-0.68 | $3.72 | $1.71 | $12.60 |
Total Assets | $413.55B | $389.40B | $379.27B | $360.32B |
Total Liabilities | $399.59B | $377.07B | $366.63B | $350.00B |
Cash & Equivalents | $453.00M | $824.00M | $628.00M | $633.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 496.37M | 561.49M | 621.66M | 645.00M |